MCNEILL JONATHAN (See Remarks) sold 3.3% of their position (4.57K shares) of CRESCENT BIOPHARMA, INC. on the open market
Open‑market sale worth $77.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/18/2026ACC: 0001628280-26-062700
Officer· See Remarks
Since Jun 2025
-4.57K
Net shares
Net seller
$77.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
4.57K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
−731.00
Price / share
$17.90
Trade value
$13.08K
% of position
0.5%
9/16/2026
139.16K→138.43K
Ordinary Shares
Direct
Shares
−3.84K
Price / share
$16.71
Trade value
$64.15K
% of position
2.8%
9/18/2026
138.43K→134.59K
Total
Net shares
−4.57K
Net value
-$77.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/16/2026 | S · Sale | −731.00 | $17.90 | $13.08K | 0.5% | 139.16K | 138.43K |
| Ordinary Shares Direct | 9/18/2026 | S · Sale | −3.84K | $16.71 | $64.15K | 2.8% | 138.43K | 134.59K |
| Total | −4.57K | -$77.23K | ||||||
Derivative Transactions0
No derivative transactions reported